Search
Patexia Research
Case number 1:12-cv-02038

Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 34 Main Document (3)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 20 Notice of Appearance (1)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 39 Miscellaneous Document (16)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 9 Notice of Appearance (1)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 33 Main Document (3)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 3 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 21 Main Document (2)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 15 Notice of Appearance (1)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 1 Exhibit A to Memorandum (5)
Mar 21, 2012 10 Main Document (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 12 Notice of Appearance (1)
Mar 21, 2012 11 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 2 Affidavit of Christopher Silva (4)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 22 Main Document (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 14 Notice of Appearance (1)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 3 Exhibit 1 to Affidavit/Declaration (44)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 4 Exhibit 2 to Affidavit/Declaration (43)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 5 Exhibit 3 to Affidavit/Declaration (4)
Mar 21, 2012 6 Exhibit 4 to Affidavit/Declaration (7)
Mar 21, 2012 7 Exhibit 5 to Affidavit/Declaration (2)
Mar 21, 2012 8 Exhibit 6 to Affidavit/Declaration (4)
Mar 21, 2012 9 Exhibit 7 to Affidavit/Declaration (4)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 25 Notice of Appearance (1)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 39 Miscellaneous Document (16)
Mar 21, 2012 24 Notice of Appearance (1)
Mar 21, 2012 23 Main Document (2)
Mar 21, 2012 37 Response in Opposition to Motion (16)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 8 Rule 7.1 Corporate Disclosure Statement (1)
Mar 21, 2012 38 Affidavit in Opposition to Motion (18)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 10 Exhibit 8 to Affidavit/Declaration (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 11 Exhibit 9 to Affidavit/Declaration (3)
Mar 21, 2012 26 Notice of Appearance (1)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 42 Notice of Appearance (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 8 Rule 7.1 Corporate Disclosure Statement (1)
Mar 21, 2012 11 Main Document (2)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 9 Notice of Appearance (1)
Mar 21, 2012 14 Notice of Appearance (1)
Mar 21, 2012 3 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 8 Rule 7.1 Corporate Disclosure Statement (1)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 22 Main Document (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 25 Notice of Appearance (1)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 42 Notice of Appearance (1)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 10 Main Document (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 5 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 15 Notice of Appearance (1)
Mar 21, 2012 37 Response in Opposition to Motion (16)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 22 Main Document (2)
Mar 21, 2012 24 Notice of Appearance (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 21 Main Document (2)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 10 Main Document (2)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 33 Main Document (3)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 15 Notice of Appearance (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 9 Notice of Appearance (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 27 Main Document (2)
Mar 21, 2012 34 Main Document (3)
Mar 21, 2012 21 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 8 Rule 7.1 Corporate Disclosure Statement (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 22 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 3 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 20 Notice of Appearance (1)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 11 Main Document (2)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 20 Notice of Appearance (1)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 26 Notice of Appearance (1)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 12 Notice of Appearance (1)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 12 Notice of Appearance (1)
Mar 21, 2012 38 Affidavit in Opposition to Motion (18)
Mar 21, 2012 23 Main Document (2)
Mar 21, 2012 10 Main Document (2)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 39 Miscellaneous Document (16)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 26 Notice of Appearance (1)
Mar 21, 2012 42 Notice of Appearance (1)
Mar 21, 2012 23 Main Document (2)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 21 Main Document (2)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 38 Affidavit in Opposition to Motion (18)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 36 Main Document (20)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 14 Notice of Appearance (1)
Mar 21, 2012 1 Exhibit 1 (14)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 9 Notice of Appearance (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 27 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 37 Response in Opposition to Motion (16)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 42 Notice of Appearance (1)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 35 Main Document (2)
Mar 21, 2012 20 Notice of Appearance (1)
Mar 21, 2012 3 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 11 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 12 Notice of Appearance (1)
Mar 21, 2012 14 Notice of Appearance (1)
Mar 21, 2012 15 Notice of Appearance (1)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 31 ADR - Miscellaneous (3)
Mar 21, 2012 23 Main Document (2)
Mar 21, 2012 1 Proposed Order (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 24 Notice of Appearance (1)
Mar 21, 2012 37 Response in Opposition to Motion (16)
Mar 21, 2012 25 Notice of Appearance (1)
Mar 21, 2012 32 Miscellaneous Document (1)
Mar 21, 2012 24 Notice of Appearance (1)
Mar 21, 2012 38 Affidavit in Opposition to Motion (18)
Mar 21, 2012 26 Notice of Appearance (1)
Mar 21, 2012 1 Main Document (17)
Mar 21, 2012 1 Civil Cover Sheet (2)
Mar 21, 2012 2 Exhibit A (19)
Mar 21, 2012 3 Exhibit B (15)
Mar 21, 2012 25 Notice of Appearance (1)
Mar 21, 2012 30 Miscellaneous Document (4)
Mar 21, 2012 4 Exhibit C (16)
Mar 21, 2012 5 Exhibit D (16)
Mar 21, 2012 5 Rule 7.1 Corporate Disclosure Statement (2)
Mar 21, 2012 6 Exhibit E (18)
Mar 21, 2012 7 Exhibit F (23)
Mar 21, 2012 8 Exhibit G (22)
Mar 21, 2012 9 Exhibit H (13)
Mar 21, 2012 10 Exhibit I (19)
Mar 21, 2012 16 Answer to Counterclaim (7)
Mar 21, 2012 11 Exhibit J (15)
Mar 21, 2012 17 ADR - Miscellaneous (2)
Mar 21, 2012 12 Summons Mylan, Inc. (2)
Mar 21, 2012 13 Summons Myland Pharmaceuticals, Inc. (2)
Mar 21, 2012 39 Miscellaneous Document (16)
Mar 21, 2012 7 Main Document (31)
Mar 21, 2012 19 Miscellaneous Document (7)
Mar 21, 2012 1 Exhibit 1 (14)
Menu